Older patients’ experiences and perceptions of participation in medical decision-making for advanced cancer

Shared decision-making (SDM) is increasingly emphasized in cancer care, particularly for older patients with complex conditions. In Korea, nearly half of new cancer diagnoses occur in adults aged 65 and older. Yet research on treatment decision-making among these patients remains limited. These patients face unique challenges, including cognitive decline, complex medical information, and family-centered decision-making, shaped in part by Confucian cultural values. This study aimed to identify experiences and willingness to participate in treatment decision-making in this population, and patient-reported factors associated with participation in SDM. This cross-sectional survey enrolled patients aged 75 and older with advanced cancer undergoing first- or second-line chemotherapy at two tertiary hospitals in the Seoul metropolitan area between August and November 2024. A customized questionnaire addressed decision-making experiences, influencing factors, authority preferences, and information needs via one-on-one interviews. Of 201 participants, 194 were included after excluding ineligible or incomplete cases. Analyses were descriptive and bivariate. Mean age was 78.8 years; 63.4% were male. Physician-led decision-making was most often ranked first (35.6%), followed by patient-autonomous (33.0%) and shared styles. Nearly all (99.5%) wanted detailed treatment information, and 65.5% needed more advice and information. When asked about a hypothetical medically irreversible condition, 75.3% would not want to continue life-sustaining treatment, and 55.7% would decline cancer treatment if their prognosis were poor. Most agreed that their own willingness (89.2%), family opinions (73.7%), and physicians’ opinions (97.4%) were important in treatment decisions. Among 13 patients prioritizing treatment cost, family was more often the primary decision-maker and uncertainty about what to do was more common, but this small subgroup does not support firm conclusions. Over half (52.1%) would use a counselor for additional explanation even at extra cost. Participants reported that their own wishes and the opinions of family and physicians mattered, and nearly all wanted detailed treatment information. Preferences for decision-making styles were diverse, with physician-led approaches most often ranked first. These descriptive findings suggest that decision support should respect patients’ stated wishes while accommodating family involvement; whether structured SDM support improves decisions requires further study.

Authors

Institutions

Publication Details

Journal
BMC Medical Ethics
Published
2026-11-14
DOI
https://doi.org/10.1186/s12910-026-01646-6
Primary Topic
Patient-Provider Communication in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Older patients’ experiences and perceptions of participation in medical decision-making for advanced cancer

Ilhak Lee, Si Won Lee, Jin Won Kim
BMC Medical Ethics
Patient-Provider Communication in Healthcare
article

Older patients’ experiences and perceptions of participation in medical decision-making for advanced cancer

Ilhak Lee, Si Won Lee, Jin Won Kim
article en

Abstract

Shared decision-making (SDM) is increasingly emphasized in cancer care, particularly for older patients with complex conditions. In Korea, nearly half of new cancer diagnoses occur in adults aged 65 and older. Yet research on treatment decision-making among these patients remains limited. These patients face unique challenges, including cognitive decline, complex medical information, and family-centered decision-making, shaped in part by Confucian cultural values. This study aimed to identify experiences and willingness to participate in treatment decision-making in this population, and patient-reported factors associated with participation in SDM. This cross-sectional survey enrolled patients aged 75 and older with advanced cancer undergoing first- or second-line chemotherapy at two tertiary hospitals in the Seoul metropolitan area between August and November 2024. A customized questionnaire addressed decision-making experiences, influencing factors, authority preferences, and information needs via one-on-one interviews. Of 201 participants, 194 were included after excluding ineligible or incomplete cases. Analyses were descriptive and bivariate. Mean age was 78.8 years; 63.4% were male. Physician-led decision-making was most often ranked first (35.6%), followed by patient-autonomous (33.0%) and shared styles. Nearly all (99.5%) wanted detailed treatment information, and 65.5% needed more advice and information. When asked about a hypothetical medically irreversible condition, 75.3% would not want to continue life-sustaining treatment, and 55.7% would decline cancer treatment if their prognosis were poor. Most agreed that their own willingness (89.2%), family opinions (73.7%), and physicians’ opinions (97.4%) were important in treatment decisions. Among 13 patients prioritizing treatment cost, family was more often the primary decision-maker and uncertainty about what to do was more common, but this small subgroup does not support firm conclusions. Over half (52.1%) would use a counselor for additional explanation even at extra cost. Participants reported that their own wishes and the opinions of family and physicians mattered, and nearly all wanted detailed treatment information. Preferences for decision-making styles were diverse, with physician-led approaches most often ranked first. These descriptive findings suggest that decision support should respect patients’ stated wishes while accommodating family involvement; whether structured SDM support improves decisions requires further study.

BMC Medical Ethics
Seoul National University (KR), Yonsei University (KR), Seoul National University Bundang Hospital (KR), St. Mary's Hospital (US)
Patient-Provider Communication in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon